Mutations in Mig6 reduce inhibition of the epidermal growth factor receptor (vol 38, e70194, 2024)

被引：0
|
作者：
Hayashi, S. Y.
Pak, S.
Torlentino, A.
Rizzo, R. C.
Miller, M. T.
机构：
来源：
FASEB JOURNAL | 2025年 / 39卷 / 07期
关键词：
D O I：
10.1096/fj.202500971
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Intratumor heterogeneity of epidermal growth factor receptor mutations in lung cancer and its correlation to the response to gefitinib (vol 99, pg 929, 2008)
    Taniguchi, K.
    Okami, J.
    Kodama, K.
    Higashiyama, M.
    K, Kato
    CANCER SCIENCE, 2008, 99 (09) : 1869 - 1869
  • [32] Epidermal growth factor receptor ligands enriched in follicular fluid exosomes promote oncogenesis of fallopian tube epithelial cells (vol 24, 424, 2024)
    Khine, Aye Aye
    Chen, Pao-Chu
    Chen, Ying-Hsi
    Chu, Sung-Chao
    Huang, Hsuan-Shun
    Chu, Tang-Yuan
    CANCER CELL INTERNATIONAL, 2025, 25 (01)
  • [33] Epidermal Growth Factor Receptor Family Inhibition Identifies P38 Mitogen-activated Protein Kinase as a Potential Therapeutic Target in Bladder Cancer
    Vidal, Regina Mora
    da Mota, Sergio Regufe
    Hayden, Annette
    Markham, Hannah
    Douglas, James
    Packham, Graham
    Crabb, Simon J.
    UROLOGY, 2018, 112 : 225.e1 - 225.e7
  • [34] Ganglioside GM1 promotes contact inhibition of growth by regulating the localization of epidermal growth factor receptor from glycosphingolipid-enriched microdomain to caveolae (vol 52, e12639, 2019)
    Zhuo, Dinghao
    Guan, Feng
    CELL PROLIFERATION, 2020, 53 (01)
  • [35] eIF4E Expression Predicts Apoptosis in Response to Epidermal Growth Factor Receptor Inhibition and Mammalian Target of Rapamycin Inhibition in Triple Negative Breast Cancers
    Liu, T.
    Yacoub, R.
    Sun, S-Y
    Graham, T.
    Tighiouart, M.
    Yang, L.
    O'Regan, R. M.
    CANCER RESEARCH, 2009, 69 (24) : 791S - 791S
  • [36] Predicting epidermal growth factor receptor mutation status of lung adenocarcinoma based on PET/CT images using deep learning (vol 14, 1458374, 2024)
    Huang, Lele
    Kong, Weifang
    Luo, Yongjun
    Xie, Hongjun
    Liu, Jiangyan
    Zhang, Xin
    Zhang, Guojin
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [37] Angiotensin II type 2 receptor inhibits epidermal growth factor receptor transactivation by increasing association of SHP-1 tyrosine phosphatase (vol 38, pg 367, 2001)
    Shibasaki, Y.
    HYPERTENSION, 2013, 62 (01) : E3 - E3
  • [38] Low Expression of the E3 Ubiquitin Ligase CBL Confers Chemoresistance in Human Pancreatic Cancer and Is Targeted by Epidermal Growth Factor Receptor Inhibition
    Kadera, Brian E.
    Toste, Paul A.
    Wu, Nanping
    Li, Luyi
    Nguyen, Andrew H.
    Dawson, David W.
    Donahue, Timothy R.
    CLINICAL CANCER RESEARCH, 2015, 21 (01) : 157 - 165
  • [39] Multi-targeted inhibition of the epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor (VEGFR) pathways: a phase I study of cetuximab (C), erlotinib (E), and bevacizumab (B) in patients with solid tumors
    Lin, C.
    Preston, G.
    Calvo, E.
    Papadopoulos, K.
    Patnaik, A.
    Sarantopoulos, J.
    O'Rourke, P.
    Takimoto, C.
    Tolcher, A.
    EJC SUPPLEMENTS, 2006, 4 (12): : 62 - 62
  • [40] Article on mutations in the tyrosine kinase domain of the epidermal growth factor receptor in non-small cell lung cancer (vol 11, pg 2106, 2005)
    Yang, SH
    Mechanic, LE
    Yang, P
    CLINICAL CANCER RESEARCH, 2005, 11 (21) : 7960 - 7961
12345